Key facts
- It has raised $20.0M; the latest was Later Stage VC ($17.0M) in Sep 2024.
- Notable investors include Innovationsstarter, AI.Fund, APEX Ventures, 11k Ventures, European Innovation Council (Belgium) — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Mindpeak
- ·The full record, as it builds
Funding rounds
No funding rounds for Mindpeak are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mindpeak
Developer of an artificial intelligence-based visual diagnosis platform designed to make microscopical analysis accessible to everyone. The company's platform assists pathologists in identifying and quantifying the tumorous region and detecting breast cancer cells through automation tools and quantification of cells or biomarkers, enabling doctors to get cancer diagnostic tools that are accessible and cost-effective in clinical environments.
- Sector
- Healthcare
- HQ
- Hamburg, Germany
- Founded
- 2018
- Employees
- 35
- Website
- mindpeak.ai/
- Ownership
- Privately Held (backing)
Mindpeak doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mindpeak shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mindpeak in its N-PORT filings yet. We sweep new filings monthly.